Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Hematopoietic Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Practice Guidelines From the American Society for Transplantation and Cellular Therapy.
Journal: Transplantation and cellular therapy
Published: August 10, 2026
The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.
Journal: The American journal of surgical pathology
Published: April 20, 2026
Protein S-acylation dynamics provide metabolic plasticity to acute myeloid leukemia cells.
Journal: bioRxiv : the preprint server for biology
Published: March 16, 2026
Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Journal: Blood
Published: March 03, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 11, 2026
Therapy-persistent leukemia is selectively vulnerable to SLC23A1 restoration via targeting KHSRP.
Journal: Blood cancer discovery
Published: January 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and Decitabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2025
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2025
Durable post-transplant survival after first-line tagraxofusp for blastic plasmacytoid dendritic cell neoplasm.
Journal: Leukemia & lymphoma
Published: December 17, 2025
Early persistence of recipient stem-cells and T-cell dysregulation are associated with relapse after transplant in AML/MDS.
Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025
Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Optimizing capillary leak syndrome prevention and management in patients receiving tagraxofusp for blastic plasmacytoid dendritic cell neoplasm.
Journal: Leukemia & lymphoma
Published: October 24, 2025
Last Updated: 09/26/2026